Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 29, 2015 2:46 PM ET

Life Sciences Tools and Services

Company Overview of ForteBio, Inc.

Company Overview

ForteBio, Inc. develops instrumentation for biotherapeutic drug discovery and development. It offers analytical systems that enable real-time analysis of biomolecular interactions, such as protein quantification and characterization of protein-protein interactions, etc. in micro-volume sample sizes. The company offers Octet systems that include instruments, biosensors, reagents, and assay kits for the analysis of biomolecular interactions, as well as to enable real-time and label-free analysis for the determination of affinity, kinetics, and concentration. Its Octet systems also enable large molecule characterization and small molecule and fragment analysis. The company also offers BlItz Sys...

1360 Willow Road

Menlo Science & Technology Park

Suite 201

Menlo Park, CA 94025

United States

Founded in 2001





Key Executives for ForteBio, Inc.

Chief Executive Officer, President and Director
Age: 62
Vice President of Product Development & Operations and General Manager
Age: 45
Vice President of China Operations
Executive Officer
Age: 56
Vice President Marketing
Compensation as of Fiscal Year 2015.

ForteBio, Inc. Key Developments

Pall ForteBio LLC Launches Octet K2 System

Pall ForteBio LLC announced the launch of the Octet K2 system, a new entry point into the Octet line of label-free interaction analysis systems. Available in Asia and Europe, the Octet K2 system offers high-performance, budget-friendly kinetic characterization of antibody, protein, and small molecule binding interactions. Using Pall ForteBio’s Bio-Layer Interferometry (BLI) technology, the systems in the Octet family offer a fluidics-free alternative to surface plasmon resonance (SPR) with a variety of off-the-shelf Dip and Read™ biosensors for more rapid assay development and optimization. The Octet K2 system increases accessibility to BLI in a low-throughput, 2-channel instrument that provides exquisite binding affinity data, even for molecules down to 150 daltons in size.

ForteBio, Inc. Launches New Interaction Analysis System

ForteBio, Inc. has launched the Octet HTX system, the new member of the Octet line of label-free interaction analysis systems. The Octet HTX system addresses the acute industry need for increased analysis speed and sample throughput when characterizing large numbers of therapeutic candidates, the company said. Octet systems provide unique insights into drug-target binding interactions, insights that are used to fine-tune the affinity and specificity of drug molecules. The Octet HTX instrument performs kinetic analysis of up to 96 binding interactions simultaneously, a capability offered by no other stand-alone label-free platform. In addition, the Octet HTX performs full 96-well plate determinations of protein concentrations in as little as 2 minutes.

Similar Private Companies By Industry

Company Name Region
QED Technologies, Inc. United States
Exeter Life Sciences, Inc. United States
Marligen Biosciences Inc. United States
Dune Sciences, Inc. United States
ApoCell, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ForteBio, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at